共 50 条
Pulmonary Function and Pretransplant Evaluation of the Hematopoietic Cell Transplant Candidate
被引:10
|作者:
Cheng, Guang-Shing
[1
,2
,3
]
机构:
[1] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1100 Fairview Ave North,D5-360, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Div Pulm & Crit Care Med, 1959 NE Pacific,Campus Box 356522, Seattle, WA 98195 USA
[3] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North,D5-360, Seattle, WA 98109 USA
关键词:
Pretransplant evaluation;
Hematopoietic cell transplantation;
Pulmonary function tests;
Pulmonary complications;
Risk assessment;
FEV1;
DLCO;
TOTAL-BODY IRRADIATION;
CONSENSUS DEVELOPMENT PROJECT;
BONE-MARROW-TRANSPLANTATION;
FUNCTION TESTING PRIOR;
WORKING GROUP-REPORT;
LUNG-FUNCTION;
COMORBIDITY INDEX;
CLINICAL-TRIALS;
RISK-ASSESSMENT;
MORTALITY;
D O I:
10.1016/j.ccm.2016.12.014
中图分类号:
R56 [呼吸系及胸部疾病];
学科分类号:
摘要:
Pretransplant pulmonary function tests provide baseline data by which to reference subsequent respiratory impairment, as well as important prognostic information, for the hematopoietic cell transplant (HCT) recipient. Abnormalities in forced expiratory volume in 1 second and diffusing capacity of carbon monoxide are associated with early respiratory failure and increased all-cause mortality after allogeneic HCT. These parameters have been incorporated into risk assessment calculators that may aid in clinical decision making. This article discusses the clinical implications of pulmonary function parameters and other risk factors for pulmonary complications in the context of evolving allogeneic HCT practice.
引用
收藏
页码:307 / +
页数:12
相关论文